Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
14.78
+0.01 (0.03%)
Aug 14, 2025, 1:46 PM - Market open

Takeda Pharmaceutical Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Net Income
136,923107,928144,067317,017230,059376,005
Upgrade
Depreciation & Amortization
710,398720,982695,415664,400583,151559,671
Upgrade
Other Amortization
40,41440,41432,587---
Upgrade
Loss (Gain) From Sale of Assets
-18,878-5,703-1,780-6,797-7,174-232,102
Upgrade
Asset Writedown & Restructuring Costs
82,886106,529150,01764,39454,51525,452
Upgrade
Loss (Gain) From Sale of Investments
174-60220,7573,991-11,19559,277
Upgrade
Loss (Gain) on Equity Investments
3,8103,986-6,4738,63015,367-76
Upgrade
Stock-Based Compensation
74,01272,86770,87160,67243,37437,663
Upgrade
Other Operating Activities
85,44170,153-133,114-109,887116,403-90,740
Upgrade
Change in Accounts Receivable
36,868-58,95915,10475,127127,294-9,316
Upgrade
Change in Inventory
-37,963-34,973-115,743-79,155-46,14825,978
Upgrade
Change in Accounts Payable
2,557-7,118-9,895-84,804125,15736,620
Upgrade
Change in Other Net Operating Assets
-14,34141,678-145,46963,568-107,698222,499
Upgrade
Operating Cash Flow
1,102,3011,057,182716,344977,1561,123,1051,010,931
Upgrade
Operating Cash Flow Growth
38.78%47.58%-26.69%-13.00%11.10%50.94%
Upgrade
Capital Expenditures
-191,267-200,795-175,420-140,657-123,252-111,206
Upgrade
Sale of Property, Plant & Equipment
6,454788,6069621,81546,453
Upgrade
Cash Acquisitions
-----49,672-
Upgrade
Divestitures
46,90620,55619,9597,95828,196530,388
Upgrade
Sale (Purchase) of Intangibles
-93,844-147,046-305,310-493,032-62,785-125,262
Upgrade
Investment in Securities
-2,831-11,4071,25512,1038,58062,008
Upgrade
Other Investing Activities
-8,978-28,446-12,9525,564-1,007-8,851
Upgrade
Investing Cash Flow
-243,560-367,060-463,862-607,102-198,125393,530
Upgrade
Short-Term Debt Issued
-27,490277,00040,000--
Upgrade
Long-Term Debt Issued
-1,024,460100,00075,000249,3341,179,515
Upgrade
Total Debt Issued
727,8671,051,950377,000115,000249,3341,179,515
Upgrade
Short-Term Debt Repaid
-----2-149,043
Upgrade
Long-Term Debt Repaid
--1,366,264-375,487-400,071-849,809-1,690,976
Upgrade
Total Debt Repaid
-1,471,772-1,366,264-375,487-400,071-849,811-1,840,019
Upgrade
Net Debt Issued (Repaid)
-743,905-314,3141,513-285,071-600,477-660,504
Upgrade
Repurchase of Common Stock
-101,581-51,860-2,326-26,929-77,531-2,141
Upgrade
Common Dividends Paid
-309,683-302,498-287,188-279,416-283,665-283,357
Upgrade
Other Financing Activities
-127,537-82,753-66,415-117,732-108,592-142,352
Upgrade
Financing Cash Flow
-1,282,706-751,425-354,416-709,148-1,070,265-1,088,354
Upgrade
Foreign Exchange Rate Adjustments
-31,040-11,38526,20422,92928,75812,501
Upgrade
Net Cash Flow
-455,005-72,688-75,730-316,165-116,527328,608
Upgrade
Free Cash Flow
911,034856,387540,924836,499999,853899,725
Upgrade
Free Cash Flow Growth
50.00%58.32%-35.34%-16.34%11.13%65.80%
Upgrade
Free Cash Flow Margin
20.33%18.69%12.69%20.77%28.02%28.14%
Upgrade
Free Cash Flow Per Share
567.59533.47342.28532.85633.95571.78
Upgrade
Cash Interest Paid
114,210112,984100,375108,555108,207107,350
Upgrade
Cash Income Tax Paid
147,907150,413202,039185,966140,423201,687
Upgrade
Levered Free Cash Flow
718,927735,617119,407480,297929,111783,893
Upgrade
Unlevered Free Cash Flow
802,107817,171191,527553,4051,005,631865,646
Upgrade
Change in Working Capital
-12,879-59,372-256,003-25,26498,605275,781
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q